Benjamin Teply, MD, MS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Sanofi
    Topic:
    Prostate Cancer
    Date added:
    03/15/2024
    Date updated:
    03/15/2024
    Relationship end date:
    07/01/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Seagen
    Topic:
    Bladder Cancer
    Date added:
    03/15/2024
    Date updated:
    03/15/2024
    Relationship end date:
    08/01/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Eli Lilly
    Topic:
    Prostate Cancer
    Date added:
    03/15/2024
    Date updated:
    03/15/2024
    Relationship end date:
    08/01/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pfizer
    Topic:
    Prostate Cancer
    Date added:
    03/15/2024
    Date updated:
    03/15/2024
    Relationship end date:
    07/01/2023
Return to Iowa Hematology Oncology Conference: Emphasis on Precision-Guided Management